Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC Patients With Brain Metastasis”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Testing effectiveness (Phase 2)Looking for participantsNCT06401824
What this trial is testing

Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases

Who this might be right for
NSCLC Stage IVBrain Metastases, Adult
Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT00372775
What this trial is testing

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 66
Large-scale testing (Phase 3)UnknownNCT01158170
What this trial is testing

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 200
Not applicableLooking for participantsNCT05033691
What this trial is testing

Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Who this might be right for
NSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more
Hadassah Medical Organization 162
Large-scale testing (Phase 3)UnknownNCT03732482
What this trial is testing

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Taizhou Hospital 400
Large-scale testing (Phase 3)UnknownNCT02972333
What this trial is testing

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Who this might be right for
EGFR-TKI Resistant MutationNonsmall Cell Lung CancerAZD9291+1 more
Shandong Cancer Hospital and Institute 150
Early research (Phase 1)Not Yet RecruitingNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Large-scale testing (Phase 3)UnknownNCT05104281
What this trial is testing

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 60
Not applicableUnknownNCT04778800
What this trial is testing

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

Who this might be right for
NSCLCBrain MetastasesLeptomeningeal Metastasis
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)UnknownNCT04193007
What this trial is testing

The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07449481
What this trial is testing

A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorBrain Metastasis
Tianjin Medical University Cancer Institute and Hospital 56
Large-scale testing (Phase 3)UnknownNCT04870190
What this trial is testing

Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases

Who this might be right for
NSCLC
Shanghai Chest Hospital 232
Early research (Phase 1)Study completedNCT02228369
What this trial is testing

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
AstraZeneca 108
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT04291092
What this trial is testing

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Who this might be right for
NSCLC Stage IVBrain MetastasesImmunotherapy
Zhejiang Cancer Hospital 63
Testing effectiveness (Phase 2)Study completedNCT00171834
What this trial is testing

Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 89
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Testing effectiveness (Phase 2)UnknownNCT05477615
What this trial is testing

Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Jin Hyoung Kang 28
Testing effectiveness (Phase 2)UnknownNCT02250846
What this trial is testing

Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC

Who this might be right for
Asymptomatic Brain Metastases of Non Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 70
Large-scale testing (Phase 3)Study completedNCT00390806
What this trial is testing

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 472
Load More Results